Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in ANIK — Anika Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$11,762
-$998 QoQ
Shares Held
804
-8.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 134 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. ANIK ranks #44 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 111,351 $3,860,538
2 UTHR
UNITED THERAPEUTICS Corp
 3,880 $2,102,300
3 ZTS
Zoetis Inc.
 24,069 $1,729,598
4 NBIX
Neurocrine Biosciences Inc
 7,270 $1,225,285
5 ELAN
Elanco Animal Health Inc
 38,301 $942,587
6 LNTH
Lantheus Holdings, Inc.
 6,773 $751,395
7 ALKS
Alkermes plc.
 6,157 $322,626
8 INDV
Indivior Pharmaceuticals, Inc.
 7,032 $288,522

All Filings in ANIK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,762 804
2026-03-31 $12,760 880
2025-12-31 $15,347 1,597
2025-09-30 $16,788 1,786
2025-06-30 $20,619 1,949
2025-03-31 $11,633 774
2024-12-31 $47,569 2,890
2024-09-30 $13,930 564
2024-06-30 $212,137 8,375
2024-03-31 $3,657 144
2023-12-31 $70,336 3,104
2023-09-30 $21,554 1,157
2023-06-30 $84,330 3,246
2023-03-31 $20,678 720
2022-12-31 $124,559 4,295
2022-09-30 $38,103 1,601
2022-06-30 $22,163 993
2022-03-31 $51,625 2,056
2021-12-31 $53,995 1,507
2021-09-30 $50,518 1,187
2021-06-30 $32,077 741
2021-03-31 $21,618 530
2020-12-31 $18,375 406
2020-09-30 $18,261 516
2020-06-30 $76,969 2,040